wink wink ( ANON I$ S E L L I N G ! ) ; - ) .....I call it "bidnesting"...Don, is that a fare assessment? Is "bidnesting a think"
My favorite part of the "BULLBOARD $CAM" is when the escorts hi-lite the "strategy" ...again Don, is that a "fare assessment? ; - )
If so, how far off can we be from word from the FDA?
"culture negative" has consistently porduced over 20% absolute efficacy. Our required numbers are based on duplicating 10.7%. The "power" equation is fluid...as are "Baysian Statistics"
DO YOU OWN due diligence and always consult a "pro" where matters of $100 or more are at risk.
Remember I only claim to have a "photo-genic" memory ; - ) wink wink
As a company or just from a pure "unescorted view" from say 2700' or 100' / per penny protocol...Spectral Medical ( T.EDT ) or Spectral Diagnostics ( T.SDI ) has achieved very considerable success throughout it's history and ESPECIALLY with our former CEO Dr. Paul Walker at the helm. Allow me to "point out" a few of the successes over the years and BEAR IN MIND the BIGGEST SUCCESS is the massive insider ownership and moreso FULL control over the 275M fully diluted shares that allow the share price to be "anything" pending time of year or in some cases "specific strategy"
Please don't be afraid to ask questions, my virtual office ( solely for the ongoing support and communication with other like-minded common shareholders is always open here on EDT Stockhouse network )..pour yourself a Canadien Cappucino ( Horten's double double )and enjoy.."AH excellent" ; - )
- 1st FDA approval was the rapid cardiac test - on it's back, the company went to $41/share in the mid/late 1990's and reached a high of > 300M CAD from a market capitalization perspective.
- In April of 2001 our current Spectral model began;
* Achieved FDA approval for the EAA in 2003 ( important to watch upcoming 15 min video )
* Stock moved to $4 CAD after approval of EAA
* EAA is the ONLY reason the current FDA phase 3B TIGRIS is a reality. The EAA is the key to personalized medicine, as described in 15 min video.
* We own 100% of the EAA, like fine wine, 20 years later it's true importance is emerging
* Bear in mind the TIGRIS trial if successful will be the 6th FDA approval in the history of the company.
1) Cardiac rapid test - sold for 9M 2) EAA diagnostic and foundation of current phase 3B TIGRIS 3) West Nile Virus rapid test 4) SAMI hemoperfusion 5) DIMI in-clinic dialysis **home pending approval 6) PENDING PMX - "Golden Hour" awaits ; - )
Really a shame that the company has chosen to BLOCK ALL NEWS here to the US since their voluntary DE-LIST on December 14th 2016. It is strange, BUT then again so is a full-time program on Stockhouse from a select couple fellows that work Stockhouse on a FT 24/7 basis. I wonder if they are in the greater Toronto region F/T or P/T? Hard to know, BUT very easy to "figure out" wink wink ; - )
Enjoy the video and enjoy the toughts from the same man that saw EVERY scrap of the phase 3 Euphrates Trial as the head of the DSMB or the "data safety monitoring board"
Bon appy les amis,
T